Research on Simbionix PROcedure Rehearsal Software Awarded Magna Cum Laude Prize at CIRSE 2009

LONDON, November 11 - Extensive research conducted by the Imperial College of London,
Ghent University Hospital and University of Sheffield on the Simbionix
PROcedure Rehearsal Studio(TM), was awarded a Magna Cum Laude EPOS Award at
the CIRSE 2009 congress in Lisbon, Portugal.

The PROcedure Rehearsal Studio(TM), introduced by Simbionix last
year, is the world's first patient specific system to enable clinicians to
create practice scenarios based on their patient's unique anatomy as
reconstructed from CTA or MRA data.

Preliminary data from ongoing research by the European Virtual
Reality Endovascular Research Team (EVEResT) suggests that patient-specific
rehearsal may enhance the performance of interventionalists in
subsequent endovascular procedures. The preliminary data also suggested that
after rehearsal, endovascular surgery is carried out more rapidly with less
use of contrast and fluoroscopy and to a higher qualitative standard,
compared to those interventions preceded by a generic warm-up case, or no
warm-up at all.

Professor Nick Cheshire, Professor of Vascular Surgery at
Imperial College remarks: "We are pleased to report on the strong correlation
between the virtual and real operation with regards to the angiography
images, endovascular access and material used during the intervention. The
Rehearsal Studio was able to adequately predict the optimal material for the
specific case at hand. Further research into the PROcedure Rehearsal
Studio(TM) is expected to determine if this technology can indeed help to
improve the technical skills of the interventionalist and tailor these skills
to the challenges of a specific patient. The preliminary results already
demonstrate shorter procedure time with less use of contrast; the end goal of
the application of this technique will of course be to enhance patient safety
and outcome."

Mr. Ran Bronstein, President and COO at Simbionix adds: "We are
very pleased with the results of the research work conducted on our newest
system. The PROcedure Rehearsal Studio(TM) is an innovative product that
utilizes a unique technology which was developed following intensive R&D
efforts. Based on initial reactions, I believe it will change the way
physicians practice and perform today."

About Imperial College Londonthe EVEResT Research Group

The EVEResT research group, led by Professor N. Cheshire, is a
multicenter collaboration between the Imperial College London in the U.K.,
the University Hospital Ghent in Belgium (Prof. F. Vermassen) and the
Sheffield Vascular Institute in the U.K.(Prof. P. Gaines).

The research group is multidisciplinary in nature, consisting of
vascular surgeons, radiologists and cardiologists. Its main goal is to
provide a platform for research into medical simulation and to aid the
process of validation and implementation of endovascular simulation as both a
training, credentialing and procedure rehearsal tool.

About Simbionix USA Corporation

Simbionix is the leader in the development and delivery of
innovative and effective virtual reality simulation products and solutions
for clinical education and training of medical professionals. The products
are designed to accelerate best-practice medical training, advance clinical
performance, and improve patient safety.

The Simbionix product line includes the ANGIO Mentor(TM) line for
endovascular procedures, LAP Mentor(TM) line for laparoscopic surgical
procedures, GI Mentor(TM) for upper and lower gastrointestinal procedures and
the URO Mentor(TM) for urological procedures. In addition, Simbionix
distributes the HystSim(TM) for hysteroscopic procedures. Each simulation
platform is a leading simulator in the relevant clinical area.

Simbionix simulation products have been validated in several
scientific studies and the company cooperates closely with both industry and
leading medical institutions to develop the most advanced simulators for the
training and assessment of medical professionals.

    Galia Zilbershtein-Salant
    Exhibition Manager
    Simbionix
    Tel: +972-8-9211177
    galia@simbionix.com

Galia Zilbershtein-Salant, Exhibition Manager, Simbionix, Tel: +972-8-9211177, galia at simbionix.com